Representing 12% y/y growth.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NBIX:
- Neurocrine Biosciences’ New Study on MDD Treatment: What Investors Need to Know
- Neurocrine Biosciences Advances Pediatric CAH Treatment with New Study
- NBIX Upcoming Earnings Report: What to Expect?
- Strong Buy Rating for Neurocrine Due to Robust Pipeline and Strategic Growth Potential
- Neurocrine initiated with a Buy at Citi